Medtronic PLC
NYSE:MDT

Watchlist Manager
Medtronic PLC Logo
Medtronic PLC
NYSE:MDT
Watchlist
Price: 86.21 USD 1.73% Market Closed
Market Cap: 110.6B USD
Have any thoughts about
Medtronic PLC?
Write Note

Medtronic PLC
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Medtronic PLC
Cost of Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Medtronic PLC
NYSE:MDT
Cost of Revenue
-$11.2B
CAGR 3-Years
-3%
CAGR 5-Years
-4%
CAGR 10-Years
-10%
Trinity Biotech PLC
NASDAQ:TRIB
Cost of Revenue
-$38.5m
CAGR 3-Years
15%
CAGR 5-Years
6%
CAGR 10-Years
3%
STERIS plc
NYSE:STE
Cost of Revenue
-$2.9B
CAGR 3-Years
-10%
CAGR 5-Years
-12%
CAGR 10-Years
-11%
No Stocks Found

Medtronic PLC
Glance View

Market Cap
110.6B USD
Industry
Health Care

Medtronic PLC, a powerhouse in the global medical technology sector, was established in 1949 and has since evolved into a key player in advancing healthcare through innovative solutions. Headquartered in Dublin, Ireland, Medtronic operates across numerous medical areas, including cardiovascular, diabetes, neurological, and surgical technologies. Their commitment to improving patient outcomes is evident in their diverse product portfolio, which includes groundbreaking devices such as insulin pumps, heart valves, and spinal implants. With a presence in over 150 countries and a robust supply chain, Medtronic is strategically positioned to address the increasing demand for healthcare solutions driven by an aging population and the growing prevalence of chronic diseases. For investors, Medtronic represents a compelling opportunity backed by strong financial fundamentals and a commitment to continuous innovation. The company has demonstrated consistent revenue growth and profitability, driven by investments in research and development that align with emerging healthcare trends. Their focus on strategic acquisitions and partnerships enhances their competitive edge, enabling them to expand into new markets and technologies. Furthermore, Medtronic's commitment to sustainability and corporate responsibility resonates with today’s socially-conscious investors. As healthcare evolves, Medtronic stands poised to lead the charge in transforming patient care, making it a worthy consideration for those looking to invest in the future of medical technology.

MDT Intrinsic Value
100.49 USD
Undervaluation 14%
Intrinsic Value
Price

See Also

What is Medtronic PLC's Cost of Revenue?
Cost of Revenue
-11.2B USD

Based on the financial report for Jul 26, 2024, Medtronic PLC's Cost of Revenue amounts to -11.2B USD.

What is Medtronic PLC's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-10%

Over the last year, the Cost of Revenue growth was -5%. The average annual Cost of Revenue growth rates for Medtronic PLC have been -3% over the past three years , -4% over the past five years , and -10% over the past ten years .

Back to Top